COMPAMIR
High-Purity Fact Pipeline
© 2026 COMPAMIR | Verified Intelligence
High-Purity Fact Pipeline
Japanese pharmaceutical companies (e.g., Astellas Pharma)
Beijing, China
June 2026
Verified: June 12, 2026
"Japanese pharmaceutical firms are increasing investments in China to leverage local drug discovery capabilities. Astellas Pharma is opening a new R&D facility in Beijing."